Redx Pharma (LSE:REDX) FCF Yield % : -59.89 (As of May. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Redx Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Redx Pharma's Trailing 12-Month Free Cash Flow is £-34.94 Mil, and Market Cap is £58.35 Mil. Therefore, Redx Pharma's FCF Yield % for today is -59.89%.

The historical rank and industry rank for Redx Pharma's FCF Yield % or its related term are showing as below:

LSE:REDX' s FCF Yield % Range Over the Past 10 Years
Min: -271.06 Med: -11.2 Max: 308.37
Current: -59.89

During the past 12 years, the highest FCF Yield % of Redx Pharma was 308.37%. The lowest was -271.06%. And the median was -11.20%.

LSE:REDX's FCF Yield % is ranked worse than
78.92% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs LSE:REDX: -59.89

Redx Pharma's FCF Margin % for the quarter that ended in Sep. 2023 was -851.98%.

Redx Pharma FCF Yield % Historical Data

The historical data trend for Redx Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma FCF Yield % Chart

Redx Pharma Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Yield %

Get a 7-Day Free Trial

-46.41

0.30

-9.40

-4.61

-40.13

Redx Pharma Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
FCF Yield %	Get a 7-Day Free Trial															-8.72	2.37	-11.80	-36.28	-37.00

Competitive Comparison of Redx Pharma's FCF Yield %

For the Biotechnology subindustry, Redx Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redx Pharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Redx Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Redx Pharma's FCF Yield % falls into.

Redx Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Redx Pharma's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-34.942	/	87.07686
	=	-40.13%

Redx Pharma's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-16.111	*	2	/	87.07686
	=	-37.00%

Redx Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Redx Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Redx Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Redx Pharma (LSE:REDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (LSE:REDX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG

Website

https://www.redxpharma.com

Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (LSE:REDX) Headlines

No Headlines